Global Blood Therapeutics announces proposed public offering of common stock
Global Blood Therapeutics announced an agreement to sell $100.0 million in shares of its common stock in a registered underwritten public offering. In addition, GBT has granted the underwriter a 30-day option to purchase up to $15.0 million in shares of its common stock. December 14, 2017